Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00869817 · ClinicalTrials.gov registry record
Dominantly Inherited Alzheimer Network (DIAN)
A clinical trial of Alzheimers Disease, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 700
- Enrollment target
- 20
- Study locations
NCT00869817 is a study of Alzheimers Disease that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 700 participants, below the 4,056-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (83% lower). The trial reports 20 study locations across 13 states.
The verdict
NCT00869817, a study of Alzheimers Disease, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 700 participants
- Enrollment target
- 20
- Study locations
Study Summary
The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
Conditions Studied
Study Locations (20)
Other
- Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia" (FLENI) Instituto de Investigaciones Neurológicas Raúl Correa - Buenos Aires
- Fundación para la Lucha contra las Enfermedades Neurológicas de la Infancia (FLENI) - Salta
- Hospital das Clinicas da Faculdade de Medicina da Universidade de São Paulo - São Paulo
- Grupo Neurociencias de Antioquia - Medellín
- German Center for Neurodegenerative Diseases (DZNE) Munich, and University Hospital Ludwig-Maximilians-Universitat (LMU) Munich - Munich
- German Center for Neurodegenerative Diseases (DZNE) Tübingen and Hertie-Institute for Clinical Brain Research, University of Tübingen - Tübingen
- Niigata University - Niigata
- Osaka City University - Osaka
Florida
- Mayo Clinic Jacksonville - Jacksonville
Indiana
- Indiana University-Indiana Alzheimer Disease Center - Indianapolis
Massachusetts
- Brigham and Women's Hospital - Boston
Missouri
- Washington University in St. Louis School of Medicine - St Louis
New York
- Columbia University - New York
Pennsylvania
- University of Pittsburgh - Pittsburgh
Rhode Island
- Butler Hospital - Providence
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 700 participants |
| Start Date | 2009-01 |
| Est. Completion | 2026-07 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00869817
The ClinicalTrials.gov registry entry for NCT00869817 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 4,056-participant average among 142 other Alzheimers Disease trials with a reported enrollment target (83% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Alzheimers Disease appearing as the primary indexed condition, and to 0 interventions.
NCT00869817 reports 20 study locations spanning 13 distinct geographic areas - top geographies include Other, Florida, Indiana.
Frequently Asked Questions
What is clinical trial NCT00869817 about?
NCT00869817 is a clinical study titled "Dominantly Inherited Alzheimer Network (DIAN)". The purpose of this study is to identify potential biomarkers that may predict the development of Alzheimer's disease in people who carry an Alzheimer's mutation.
What is the current status of trial NCT00869817?
This trial is currently recruiting. The enrollment target is 700 participants. The study started on 2009-01. Estimated completion is 2026-07.
What conditions does trial NCT00869817 study?
This clinical trial studies the following conditions: Alzheimers Disease.
Who is sponsoring clinical trial NCT00869817?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00869817 being conducted?
This trial has 20 study locations across Florida, Indiana, Massachusetts, Missouri, New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Alzheimers Disease
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
RECRUITING · Phase 3
-
Assessment of Foralumab Safety and Modulation of Microglial Activation in Alzheimer's Disease
RECRUITING · Phase 2
-
University of Central Florida Music Study
RECRUITING · NA
-
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
RECRUITING · Phase 2
-
A Study of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
RECRUITING · Phase 3
-
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RECRUITING · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.